CRMD
CRMD
NASDAQ · Pharmaceuticals

Cormedix Inc

$7.44
-0.07 (-0.93%)
As of Aug 8, 10:19 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +605.6% upside
Low Target $41.99
Average Target $52.50
High Target $66.46
Current Price $7.44
Current
$7.44
Target
$52.50
$41.99 $52.50 avg $66.46
Scenario Analysis
Bear Case
$41.99
464.4%
Low target
Base Case
$52.50
+605.6%
Avg target
Bull Case
$66.46
+793.3%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$14.96
-50.3% from high
52-Week Low
$6.13
+21.4% from low
Target vs 52W High
$52.50
+250.9% vs high
Next Earnings Report
Aug 13, 2026 · Before Market Open
3d
until earnings
EPS Est: $0.24
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%